| Dr Randy Joe Hartman, MD | |
|
100 Hillcrest Medical Blvd, Waco, TX 76712 | |
| (254) 202-2000 | |
| Not Available |
| Full Name | Dr Randy Joe Hartman |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 100 Hillcrest Medical Blvd, Waco, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598927907 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | N1673 (Texas) | Primary |
| Entity Name | Legacy Urgent Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568622272 PECOS PAC ID: 3072679828 Enrollment ID: O20090304000140 |
News Archive
Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.
The first ever published study of aviation-related injuries and deaths in the U.S. finds an average of 1,013 patients are admitted to U.S. hospitals with aviation-related injuries annually, and that an average of 753 aviation-deaths occur each year.
BioImagene, Inc., the leading provider of end-to-end digital pathology solutions, announced the integration of Virtuoso™, BioImagene's digital pathology workflow software, with several market-leading anatomic pathology laboratory information systems.
A recent electronic survey of US asthma experts demonstrated the need for better access to levalbuterol, the fast-acting medicine used to treat the narrowing of airways (bronchospasm) caused by asthma, for selected patients.
Cellectis bioresearch, the genome customization specialist and a commercial subsidiary of Cellectis, and Lonza, a world leader in biotechnology production, announce today that they have reached a significant milestone in the development of a newly bioengineered cell line.
› Verified 1 days ago
| Entity Name | Century Integrated Partners, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447615711 PECOS PAC ID: 6406151703 Enrollment ID: O20160224002152 |
News Archive
Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.
The first ever published study of aviation-related injuries and deaths in the U.S. finds an average of 1,013 patients are admitted to U.S. hospitals with aviation-related injuries annually, and that an average of 753 aviation-deaths occur each year.
BioImagene, Inc., the leading provider of end-to-end digital pathology solutions, announced the integration of Virtuoso™, BioImagene's digital pathology workflow software, with several market-leading anatomic pathology laboratory information systems.
A recent electronic survey of US asthma experts demonstrated the need for better access to levalbuterol, the fast-acting medicine used to treat the narrowing of airways (bronchospasm) caused by asthma, for selected patients.
Cellectis bioresearch, the genome customization specialist and a commercial subsidiary of Cellectis, and Lonza, a world leader in biotechnology production, announce today that they have reached a significant milestone in the development of a newly bioengineered cell line.
› Verified 1 days ago
| Entity Name | Premier Physicians - Ii Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801204656 PECOS PAC ID: 9234416744 Enrollment ID: O20170511000584 |
News Archive
Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.
The first ever published study of aviation-related injuries and deaths in the U.S. finds an average of 1,013 patients are admitted to U.S. hospitals with aviation-related injuries annually, and that an average of 753 aviation-deaths occur each year.
BioImagene, Inc., the leading provider of end-to-end digital pathology solutions, announced the integration of Virtuoso™, BioImagene's digital pathology workflow software, with several market-leading anatomic pathology laboratory information systems.
A recent electronic survey of US asthma experts demonstrated the need for better access to levalbuterol, the fast-acting medicine used to treat the narrowing of airways (bronchospasm) caused by asthma, for selected patients.
Cellectis bioresearch, the genome customization specialist and a commercial subsidiary of Cellectis, and Lonza, a world leader in biotechnology production, announce today that they have reached a significant milestone in the development of a newly bioengineered cell line.
› Verified 1 days ago
| Entity Name | Ies Central Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003523002 PECOS PAC ID: 3476922576 Enrollment ID: O20221213000355 |
News Archive
Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.
The first ever published study of aviation-related injuries and deaths in the U.S. finds an average of 1,013 patients are admitted to U.S. hospitals with aviation-related injuries annually, and that an average of 753 aviation-deaths occur each year.
BioImagene, Inc., the leading provider of end-to-end digital pathology solutions, announced the integration of Virtuoso™, BioImagene's digital pathology workflow software, with several market-leading anatomic pathology laboratory information systems.
A recent electronic survey of US asthma experts demonstrated the need for better access to levalbuterol, the fast-acting medicine used to treat the narrowing of airways (bronchospasm) caused by asthma, for selected patients.
Cellectis bioresearch, the genome customization specialist and a commercial subsidiary of Cellectis, and Lonza, a world leader in biotechnology production, announce today that they have reached a significant milestone in the development of a newly bioengineered cell line.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Randy Joe Hartman, MD Po Box 844658, Dallas, TX 75284-4658 Ph: (800) 944-0371 | Dr Randy Joe Hartman, MD 100 Hillcrest Medical Blvd, Waco, TX 76712 Ph: (254) 202-2000 |
News Archive
Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.
The first ever published study of aviation-related injuries and deaths in the U.S. finds an average of 1,013 patients are admitted to U.S. hospitals with aviation-related injuries annually, and that an average of 753 aviation-deaths occur each year.
BioImagene, Inc., the leading provider of end-to-end digital pathology solutions, announced the integration of Virtuoso™, BioImagene's digital pathology workflow software, with several market-leading anatomic pathology laboratory information systems.
A recent electronic survey of US asthma experts demonstrated the need for better access to levalbuterol, the fast-acting medicine used to treat the narrowing of airways (bronchospasm) caused by asthma, for selected patients.
Cellectis bioresearch, the genome customization specialist and a commercial subsidiary of Cellectis, and Lonza, a world leader in biotechnology production, announce today that they have reached a significant milestone in the development of a newly bioengineered cell line.
› Verified 1 days ago
Dr. Foy Edward Dark Iii, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1201 Hewitt Dr, Suite 203, Waco, TX 76712 Phone: 254-666-3627 Fax: 243-732-6125 | |
Dr. Timothy Michael Welter, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3000 Herring Ave, Waco, TX 76708 Phone: 254-202-8611 | |
Dr. Michelle Marie Law, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5400 Crosslake Pkwy, Waco, TX 76712 Phone: 254-420-2336 | |
Brennon Edward Barajas, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 915-474-4415 | |
Dr. Joel David Mendez, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6901 Medical Pkwy, Waco, TX 76712 Phone: 832-814-7136 | |
Dr. Weldon Louis Kunkel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 6901 Medical Parkway, Waco, TX 76712 Phone: 254-751-4146 Fax: 254-751-4283 | |
Dr. Harvey Robert Chen, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7125 New Sanger Ave Ste A, Waco, TX 76712 Phone: 254-399-5400 Fax: 254-772-8669 |